Inpatient hypertension management under the 2017 AHA/ACC guidelines

At Hospital Medicine 2017, the Society of Hospital Medicine brought hospitalists together in Las Vegas to exchange research, practical ideas and continuing education. The 2017 AHA/ACC hypertension framework shifted attention from a single office threshold to confirmed diagnosis, treatment intensity and reliable follow-up. That change mattered on crowded wards, where pain, anxiety, renal impairment or missed medicines can alter a patient's usual blood pressure.

Australian translation requires local judgement. Melbourne and Sydney hospitals face heavy emergency demand and short stays, while salt-heavy takeaway meals, shift work and over-the-counter ibuprofen can complicate blood pressure control. Medicare, the Pharmaceutical Benefits Scheme and current prescribing guidance should shape affordable treatment choices, with clinical governance teams checking the conference-era framework before changing local policy.

What changed for hospitalised patients

The threshold for hypertension fell from 140/90 mmHg to 130/80 mmHg. Readings of 130–139 systolic or 80–89 diastolic are classified as elevated; stage 1 hypertension is 130–139/80–89, and stage 2 is at least 140 systolic or 90 diastolic. A hospital measurement above either limit is a signal to verify, not an automatic prescription.

Treatment still depends on overall cardiovascular risk, existing disease and the distance from the patient's target. Stage 1 hypertension generally combines lifestyle measures with medication when risk is high or pressure remains elevated. Stage 2 usually requires two agents, whereas a person with a mildly elevated reading and low risk may need reassessment and support before medication.

For many adults with hypertension, the guideline target was below 130/80 mmHg, measured outside the clinic as well as in it. Older or frailer patients may be better served by a less intensive goal, with their function and tolerance taken into account. Shared decisions, rather than a universal number, are especially important when the evidence is less certain.

Confirming the diagnosis and setting urgency

Repeat measurements with the patient seated quietly for five minutes, feet flat and the arm supported at heart level. Use the correct cuff size, take at least two readings a minute apart, and avoid caffeine, smoking or exercise for 30 minutes beforehand. Home or ambulatory readings can expose white-coat hypertension and help identify masked hypertension before long-term treatment is started.

Severe readings around 180/120 mmHg or higher need assessment for acute target-organ injury, especially with chest pain, breathlessness, neurological deficit or acute kidney injury. Acute-care protocols, not outpatient targets, govern urgent treatment, and pressure should not be normalised rapidly. If there is no acute injury, confirm the reading and arrange a safe management pathway.

Acute illness can also raise pressure without causing hypertension. A Hospital Medicine 2017 session on interpreting rapid influenza tests showed why diagnostic results require clinical context. During Australia's winter influenza season, infection may explain fever or tachycardia and should be addressed rather than masked by antihypertensive escalation.

Matching treatment to the patient

The main first-line choices are a thiazide-type diuretic, a calcium-channel blocker, an ACE inhibitor or an ARB. If stage 2 pressure is substantially above target, two complementary agents are usually appropriate, ideally in one tablet to simplify the regimen. A drug that was previously effective should inform inpatient selection rather than being discarded without review.

Comorbidity changes the order of priorities. An ACE inhibitor or ARB is often preferred in albuminuric chronic kidney disease, while a beta-blocker may have a specific role after myocardial infarction or in systolic heart failure. Do not combine an ACE inhibitor with an ARB. In pregnancy, use pregnancy-appropriate agents such as labetalol, methyldopa or extended-release nifedipine, and avoid ACE inhibitors and ARBs.

Renal function, potassium, sodium and adverse effects need review before discharge, especially after starting or increasing a renin-angiotensin system blocker or diuretic. Medication reconciliation should include non-prescription ibuprofen, pseudoephedrine-containing products, corticosteroids, stimulants and herbal preparations. Australian pharmacists can help identify these agents, including products subject to supply controls.

Planning discharge and shared follow-up

Discharge prescribing should return the patient to a regimen they can manage, not reproduce every inpatient adjustment. Reconcile home medicines, restart appropriate antihypertensives withheld temporarily, and explain any monitoring or titration. Once-daily medicines supported by the Pharmaceutical Benefits Scheme can reduce complexity, while private prescriptions may still carry a cost that affects adherence.

Education should fit everyday Australian life: practical changes to takeaway food, less salt, regular activity suited to health, moderate alcohol and avoiding nicotine. A validated upper-arm home monitor, written instructions and a method for recording readings can make self-management realistic. Salt-substitute potassium chloride is unsuitable for some people with kidney disease or ACE inhibitor or ARB treatment.

Hospital Medicine 2017 also included informal learning beyond clinical sessions. The report on its poker tournament chip leader highlights that social side of the meeting; the transferable lesson for ward teams is to read changing circumstances, keep priorities visible and assign ownership during handover.

Arrange a specific general-practice appointment rather than relying on an unbooked follow-up. A useful Australian safety net is a repeat prescription with a review date, pharmacist support and a plan for home readings to reach the GP or practice nurse. More frequent review is needed for recent stroke, heart failure, chronic kidney disease, uncontrolled pressure or adverse effects.

Turning guidance into a local learning loop

Conference material on hospitalist research programmes offers a practical starting point for local improvement: define a focused question, appoint a clinical owner and use routinely collected data. A hospitalist team might test whether repeat readings and appropriate medication intensification occur before discharge, then compare results across ward shifts.

Measure both process and outcomes: correctly repeated readings, documented shared decisions, medication changes, hypotension, acute kidney injury and relevant readmissions. Balance measures should include patient workload and medication affordability. Australian privacy principles, including the Privacy Act 1988 and applicable state or territory health-records legislation, shape how linked data are governed, with small-cell suppression and controlled access where re-identification is possible.

Teach the change with brief, case-based huddles and give clinicians a route for escalating severe readings or acute kidney injury. Feedback works best when it is specific, timely and linked to a response. The conference's combination of formal sessions and professional networking also supports peer sharing, while audit cycles can turn local observations into testable hypotheses rather than isolated anecdotes.

A practical daily care checklist

These recommendations can be translated into a repeatable ward process:

Four habits keep the pathway safe:

• Confirm before treating: repeat measurements correctly and distinguish sustained hypertension from pain, anxiety, infection or medication effects.
• Match treatment to the person: account for kidney disease, heart failure, pregnancy plans and current medicines, then monitor renal function and electrolytes.
• Make discharge usable: simplify medicines, check affordability, explain home monitoring and book follow-up with a named clinician.
• Review performance: audit a small monthly sample of admissions and share findings with ward, pharmacy and primary-care colleagues.

The framework works best when target setting, ward routines and follow-up are treated as one pathway. A team can begin with a single measurable gap, test a change on one ward, and retain it only when evidence, patient experience and workload remain acceptable. That is the disciplined approach hospital medicine requires: careful measurement, explicit ownership and repeated review.

The immediate team task is an audit of twenty consecutive hypertension admissions before the next multidisciplinary meeting, recording repeat blood-pressure measurements, medication changes and documented follow-up.